About Thomson Reuters

Thomson Pharma is a leading information solution by Thomson Reuters.

Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world’s most trusted news organization.

Our scientific knowledge and information is essential for drug companies to discover new drugs and get them to market faster, for researchers to find relevant papers and know what's newly published in their subject, and for businesses to optimize their intellectual property and find competitive intelligence.

Today we are the established and authoritative pharmaceutical and biotechnology information resource, and the industry authority on the global generics market.

Both innovators and generic manufacturers trust us because our integrated solutions contain an unrivalled breadth and depth of timely, relevant strategic information from multiple databases, delivered on powerful platforms, accompanied by intuitive analytical tools, and backed up by dedicated support teams.

But we provide far more than just content sets. Our data are enriched with unique abstracts, commentaries and analysis prepared by our team of industry experts — critical insight on-tap from the thought leaders that shape pharmaceutical opinion.

All over the world, decision-makers depend on us for the essential knowledge that can justify their strategies, promote outstanding research and business growth, and keep them abreast of the market.

To discuss how Thomson Reuters can meet your information needs, please contact us.

For more information on Thomson Reuters, visit scientific.thomsonreuters.com.

Where next? Latest enhancements